Sleep and Cancer: Clinical Studies and Opportunities for Personalized Medicine

Springer Science and Business Media LLC - Tập 3 - Trang 11-21 - 2017
Fernando Santamaria-Martos1, Manuel Sánchez-de-la-Torre1,2, Miguel Angel Martínez-García2,3
1Group of Translational Research in Respiratory Medicine, Hospital Universitari Arnau de Vilanova and Santa Maria, IRB Lleida, Lleida, Spain
2Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain
3Pulmonology Service, University and Polytechnic La Fe Hospital, Valencia, Spain

Tóm tắt

Both cancer and sleep disorders are two of the main problems of modern society with a high impact on public health. The present review analyzes the most recent and relevant clinical and epidemiological studies that explore the relationship between cancer and shift work, cancer and sleep duration, and cancer and sleep apnea. It also reviews the limitations of the present studies and explores the future challenges in personalized medicine in this field. The latest research in sleep and cancer is contradictory due to key limitations such as study design and lack of consideration of other sleep problems apart from the specific one being analyzed. Different studies have reached opposite conclusions in regards to the association of cancer with sleep duration and sleep quality; only the association between sleep timing and cancer seems to be well established. Recent studies have identified a possible association between sleep apnea and cancer, but further studies should be performed to clearly demonstrate the putative causality of this association. There is not a clear association between specific sleep characteristics and cancer. New studies should be performed to evaluate the impact of sleep quality and sleep-related diseases, such as sleep apnea, with cancer.

Tài liệu tham khảo

Czeisler CA, Rechtschaffen A, Gilliland MA, et al. Duration, timing and quality of sleep are each vital for health, performance and safety. Sleep Health. 2015;1:5–8. Owens RL, Gold KA, Gozal D, et al. Sleep and breathing… and cancer? Cancer Prev Res. 2016. doi:10.1158/1940-6207.CAPR-16-0092. Liu Y, Wheaton AG, Chapman DP, Cunningham TJ, Lu H, Croft JB. Prevalence of healthy sleep duration among adults—United States, 2014. MMWR Morb Mortal Wkly Rep. 2016;65:137–41. Steptoe A, Peacey V, Wardle J, et al. Sleep duration and health in young adults. Arch Intern Med. 2006;166:1689. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans, volume 98. Lyon: Painting, Firefighting, and Shiftwork; 2010. Straif K, Baan R, Grosse Y, Secretan B, El Ghissassi F, Bouvard V, et al. Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol. 2007;8:1065–6. Ma Q-Q, Yao Q, Lin L, Chen G-C, Yu J-B. Sleep duration and total cancer mortality: a meta-analysis of prospective studies. Sleep Med. 2016;27–28:39–44. Erren TC, Morfeld P, Foster RG, Reiter RJ, Groß JV, Westermann IK. Sleep and cancer: synthesis of experimental data and meta-analyses of cancer incidence among some 1,500,000 study individuals in 13 countries. Chronobiol Int. 2016;33:325–50. Martínez-García MÁ, Campos-Rodríguez F, Farré R. Sleep apnoea and cancer: current insights and future perspectives. Eur Respir J. 2012. doi:10.1183/09031936.00127912. Kukwa W, Migacz E, Druc K, Grzesiuk E, Czarnecka AM. Obstructive sleep apnea and cancer: effects of intermittent hypoxia? Future Oncol. 2015. doi:10.2217/fon.15.216. Gozal D, Farré R, Nieto FJ. Obstructive sleep apnea and cancer: epidemiologic links and theoretical biological constructs. Sleep Med Rev. 2016. doi:10.1016/j.smrv.2015.05.006. Martínez-García MÁ, Campos-Rodríguez F, Almendros I, Farré R. Relación entre apnea del sueño y cáncer. Arch Bronconeumol. 2015;51:456–61. Martínez-García MÁ, Campos-Rodríguez F, Almendros I. Sleep disorders and cancer. Curr Sleep Med Rep. 2016;2:1–11. Verkasalo PK, Lillberg K, Stevens RG, Hublin C, Partinen M, Koskenvuo M, et al. Sleep duration and breast cancer: a prospective cohort study. Cancer Res. 2005. doi:10.1158/0008-5472.CAN-05-2138. Sturgeon SR, Luisi N, Balasubramanian R, Reeves KW. Sleep duration and endometrial cancer risk. Cancer Causes Control. 2012;23:547–53. Thompson CL, Li L. Association of sleep duration and breast cancer OncotypeDX recurrence score. Breast Cancer Res Treat. 2012;134:1291–5. von Ruesten A, Weikert C, Fietze I, Boeing H. Association of sleep duration with chronic diseases in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study. PLoS ONE. 2012;7:e30972. •• Zhang X, Giovannucci EL, Wu K, et al. Associations of self-reported sleep duration and snoring with colorectal cancer risk in men and women. Sleep. 2013;36:681–8. One of the first studies relating sleep duration and sleep apnea and their association with cancer. Khawaja O, Petrone AB, Aleem S, Manzoor K, Gaziano JM, Djousse L. Sleep duration and risk of lung cancer in the physicians’ health study. Zhongguo Fei Ai Za Zhi. 2014;17:649–55. Luojus MK, Lehto SM, Tolmunen T, Erkkilä AT, Kauhanen J. Sleep duration and incidence of lung cancer in ageing men. BMC Public Health. 2014;14:295. Hurley S, Goldberg D, Bernstein L, Reynolds P. Sleep duration and cancer risk in women. Cancer Causes Control. 2015;26:1037–45. Cai H, Shu X-O, Xiang Y-B, Yang G, Li H, Ji B-T, et al. Sleep duration and mortality: a prospective study of 113 138 middle-aged and elderly Chinese men and women. Sleep. 2015;38:529–36. Gu F, Xiao Q, Chu LW, Yu K, Matthews CE, Hsing AW, et al. Sleep duration and cancer in the NIH-AARP diet and health study cohort. PLoS ONE. 2016;11:e0161561. Markt SC, Flynn-Evans EE, Valdimarsdottir UA, et al. Sleep duration and disruption and prostate cancer risk: a 23-year prospective study. Cancer Epidemiol Biomarkers Prev. 2016;25:302–8. Phipps AI, Bhatti P, Neuhouser ML, et al. Pre-diagnostic sleep duration and sleep quality in relation to subsequent cancer survival. J Clin Sleep Med. 2016;12:495–503. Xiao Q, Signorello LB, Brinton LA, Cohen SS, Blot WJ, Matthews CE. Sleep duration and breast cancer risk among black and white women. Sleep Med. 2016;20:25–9. Nieto FJ, Peppard PE, Young T, Finn L, Hla KM, Farré R. Sleep-disordered breathing and cancer mortality: results from the Wisconsin Sleep Cohort Study. Am J Respir Crit Care Med. 2012. doi:10.1164/rccm.201201-0130OC. Campos-Rodriguez F, Martinez-Garcia MA, Martinez M, et al. Association between obstructive sleep apnea and cancer incidence in a large multicenter Spanish cohort. Am J Respir Crit Care Med. 2013. doi:10.1164/rccm.201209-1671OC. Marshall NS, Wong KKH, Cullen SRJ, Knuiman MW, Grunstein RR. Sleep apnea and 20-year follow-up for all-cause mortality, stroke, and cancer incidence and mortality in the Busselton Health Study cohort. J Clin Sleep Med JCSM Off Publ Am Acad Sleep Med. 2014;10:355–62. Chang W-P, Liu M-E, Chang W-C, Yang AC, Ku Y-C, Pai J-T, et al. Sleep apnea and the subsequent risk of breast cancer in women: a nationwide population-based cohort study. Sleep Med. 2014. doi:10.1016/j.sleep.2014.05.026. Chen J-C, Hwang J-H. Sleep apnea increased incidence of primary central nervous system cancers: a nationwide cohort study. Sleep Med. 2014. doi:10.1016/j.sleep.2013.11.782. Martínez-García MA, Campos-Rodriguez F, Durán-Cantolla J, et al. Obstructive sleep apnea is associated with cancer mortality in younger patients. Sleep Med. 2014. doi:10.1016/j.sleep.2014.01.020. • Martínez-Garćia M-Á, Martorell-Calatayud A, Nagore E, et al. Association between sleep disordered breathing and aggressiveness markers of malignant cutaneous melanoma. Eur Respir J. 2014. doi:10.1183/09031936.00115413. One of the first human studies that measured cancer biomarkers in OSA patients. Kendzerska T, Leung RS, Hawker G, Tomlinson G, Gershon AS. Obstructive sleep apnea and the prevalence and incidence of cancer. CMAJ. 2014. doi:10.1503/cmaj.140238. Fang H-F, Miao N-F, Chen C-D, Sithole T, Chung M-H. Risk of cancer in patients with insomnia, parasomnia, and obstructive sleep apnea: a nationwide nested case–control study. J Cancer. 2015. doi:10.7150/jca.12490. Lee S, Kim BG, Kim JW, Lee KL, Koo DL, Nam HW, et al. Obstructive sleep apnea is associated with an increased risk of colorectal neoplasia. Gastrointest Endosc. 2016. doi:10.1016/j.gie.2016.07.061. Dal Molin M, Brant A, Blackford AL, Griffin JF, Shindo K, Barkley T, et al. Obstructive sleep apnea and pathological characteristics of resected pancreatic ductal adenocarcinoma. PLoS ONE. 2016;11:e0164195. Chung SD, Hung SH, Lin HC, Tsai MC, Kao LT. Obstructive sleep apnea and urological comorbidities in males: a population-based study. Sleep Breath. 2016;20:1–6. Vilaseca A, Nguyen DP, Vertosick EA, et al. Obstructive sleep apnea and Fuhrman grade in patients with clear cell renal cell carcinoma treated surgically. World J Urol. 2016:1–6. Gozal D, Ham SA, Mokhlesi B. Sleep apnea and cancer: analysis of a nationwide population sample. Sleep 2016:1493–1500. Martínez-García MÁ, Campos-Rodriguez F, Barbé F. Cancer and OSA: current evidence from human studies. Chest. 2016. doi:10.1016/j.chest.2016.04.029. Schernhammer ES, Kroenke CH, Laden F, Hankinson SE. Night work and risk of breast cancer. Epidemiology. 2006;17:108–11. Viswanathan AN, Hankinson SE, Schernhammer ES. Night shift work and the risk of endometrial cancer. Cancer Res. 2007;67:10618–22. Hansen J. Increased breast cancer risk among women who work predominantly at night. Epidemiology. 2001;12:74–7. Kubo T, Ozasa K, Mikami K, et al. Prospective cohort study of the risk of prostate cancer among rotating-shift workers: findings from the Japan Collaborative Cohort Study. Am J Epidemiol. 2006;164:549–55. Rao D, Yu H, Bai Y, Zheng X, Xie L. Does night-shift work increase the risk of prostate cancer? A systematic review and meta-analysis. Onco Targets Ther. 2015;8:2817–26. Lin X, Chen W, Wei F, Ying M, Wei W, Xie X. Night-shift work increases morbidity of breast cancer and all-cause mortality: a meta-analysis of 16 prospective cohort studies. Sleep Med. 2015;16:1381–7. Lauderdale DS, Knutson KL, Yan LL, Liu K, Rathouz PJ. Self-reported and measured sleep duration: how similar are they? Epidemiology. 2008;19:838–45. Christensen AS, Clark A, Salo P, Nymann P, Lange P, Prescott E, et al. Symptoms of sleep disordered breathing and risk of cancer: a prospective cohort study. Sleep. 2013. doi:10.5665/sleep.3030. Palamaner Subash Shantha G, Kumar AA, Cheskin LJ, Pancholy SB. Association between sleep-disordered breathing, obstructive sleep apnea, and cancer incidence: a systematic review and meta-analysis. Sleep Med. 2015. doi:10.1016/j.sleep.2015.04.014. Zhang X-B, Peng L-H, Lyu Z, Jiang X-T, Du Y-P. Obstructive sleep apnoea and the incidence and mortality of cancer: a meta-analysis. Eur J Cancer Care (Engl). 2015. doi:10.1111/ecc.12427. Sánchez-de-la-Torre M, Barbé F. Personalized medicine in sleep apnea: towards a new paradigm of comprehensive disease management. Med Clín (English Ed). 2016. doi:10.1016/j.medcle.2016.12.004. Torres G, Sánchez-de-la-Torre M, Barbé F. Medicina de precisión: un viaje a Ítaca. Arch Bronconeumol. 2017;52:455–6. •• Sánchez-de-la-Torre M, Khalyfa A, Sánchez-de-la-Torre A, et al. Precision medicine in patients with resistant hypertension and obstructive sleep apnea. J Am Coll Cardiol. 2015;66:1023–32. One of the first approximations of personalized medicine in sleep.